Detalhe da pesquisa
1.
SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID-19: The International Study of Inflammation in COVID-19.
J Med Virol
; 96(1): e29389, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38235904
2.
Representation of Black patients in heart failure clinical trials.
Curr Opin Cardiol
; 36(3): 329-334, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33818547
3.
Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI.
J Am Soc Nephrol
; 31(11): 2725-2735, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32963090
4.
Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials.
Oncologist
; 24(1): 96-102, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30413668
5.
Biomarkers of chronic inflammation and cognitive decline: A prospective observational study.
Alzheimers Dement (Amst)
; 16(1): e12568, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38532827
6.
Permissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology.
JACC CardioOncol
; 4(3): 302-312, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36213359
7.
Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically Ill Patients With COVID-19.
Circ Cardiovasc Qual Outcomes
; 15(10): e008942, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36193749
8.
Differences in Inflammation, Treatment, and Outcomes Between Black and Non-Black Patients Hospitalized for COVID-19: A Prospective Cohort Study.
Am J Med
; 135(3): 360-368, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34793753
9.
Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor-Induced Myocarditis.
JACC CardioOncol
; 4(5): 689-700, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36636441
10.
Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19.
Diabetes Care
; 45(3): 692-700, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045184
11.
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19.
J Am Heart Assoc
; 11(18): e025198, 2022 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35924778
12.
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19.
J Am Heart Assoc
; 10(24): e023535, 2021 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34889102
13.
ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L)1 inhibitor resistance.
Oncoimmunology
; 9(1): 1744980, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32363112
14.
In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study.
BMJ
; 371: m3513, 2020 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32998872
15.
Right Ventricular Dysfunction in Critically Ill Patients With COVID-19.
Am J Cardiol
; 168: 176-178, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35090698
16.
Gender Parity in Medical School Does Not Equal Gender Parity in Medical School Leadership.
J Womens Health (Larchmt)
; 28(5): 563-564, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30985228